PT  - JOURNAL ARTICLE
AU  - Yuwen Yang
AU  - Yi Lu
AU  - Bin Jiang
TI  - Population-weighted greenspace exposure tied to lower COVID-19 mortality rates: A nationwide dose-response study
AID  - 10.1101/2022.05.24.22275549
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.05.24.22275549
4099  - http://medrxiv.org/content/early/2022/05/25/2022.05.24.22275549.short
4100  - http://medrxiv.org/content/early/2022/05/25/2022.05.24.22275549.full
AB  - The COVID-19 outbreak has caused enormous deaths and profound social and economic disruption globally. Accumulating evidence suggests exposure to greenspace may reduce the risk of COVID-19 mortality. Greenspace exposure enhances immune functioning, reduces inflammation, and replenishes gut microbiota may protect against the risk of mortality among those with COVID-19. However, previous studies often fail to distinguish the health effect of different types of greenspace, explore the dose-response association and optimal buffer distance, and consider the spatial dynamics of population distribution and geographic locations of greenspace.This study examined the associations among ratio of different types of greenspaces, population- weighted exposure to different types of greenspaces, and COVID-19 mortality rates using a negative binomial generalized linear mixed effects model across 3,025 counties, adjusted for socioeconomic, demographic, pre-existing chronic disease, policy and regulation, behavioral, and environmental factors. The population-weighted measure gave proportionally greater weight to greenspace near areas of higher population density.Exposure to forest and pasture was negatively associated with COVID-19 mortality rates, while developed open space has insignificant or positive associations with mortality rates. Forest outside park has the largest effect size across all buffer distances, followed by forest inside park. The optimal exposure buffer distance is 1km for forest outside park, with 1 unit of increase in exposure associated with a 9.9% decrease in mortality rates (95% confidence interval: 6.9% -12.8%). The optimal exposure buffer distance of forest inside park is 400m, with 1 unit of increase in exposure, associated with a 4.7% decrease in mortality rates (95% confidence interval: 2.4% - 6.9%).Greenspaces, especially nearby forest, may be effective at lowering the mortality risk of COVID-19 patients. Our findings suggest that policymakers and planners should prioritize forestry within walking distance of residential clusters to mitigate mortality rates during current and future respiratory pandemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the University Grants Committee [grant numbers 102010054.088616.01100.302.01] and the Research Grants Council of the Hong Kong SAR [grant number CityU11207520].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available human data that were originally located at: https://www.mrlc.gov/data/nlcd-2016-land-cover-conus https://usafacts.org/visualizations/coronavirus-covid-19-spread-map/ https://nccd.cdc.gov/DHDSPAtlas/Default.aspx https://theuscovidatlas.org/ https://ephtracking.cdc.gov/DataExplorer/ https://www.countyhealthrankings.org/app/arizona/2020/measure/factors/9/data https://seandavi.github.io/sars2pack/reference/descartes_mobility_data.html https://github.com/JieYingWu/COVID-19_US_County-level_Summaries/tree/master/data/out_of_home_activity https://nccd.cdc.gov/DHDSPAtlas/Default.aspx https://www.sciencebase.gov/catalog/item/4f70b1f4e4b058caae3f8e16 https://www.ncdc.noaa.gov/cag/ https://www.ncei.noaa.gov/data/global-hourly/archive/csv/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors